New target for ALS; Biomarker may help in fight against ovarian cancer; New avenue for schistosomiasis R&D;

> Researchers at Penn Medicine say they discovered that hypermethylation--the epigenetic ability to turn down or turn off a bad gene--serves as a protective barrier inhibiting the development of ALS and frontotemporal degeneration (FTD). Their work, published this month in Neurology, may suggest a neuroprotective target for drug discovery efforts. Release

> Queen's University researcher Madhuri Koti says he has discovered a biomarker that may help lead to better predictions of the success of chemotherapy in ovarian cancer patients. This discovery could lead to better treatment options against ovarian cancer. More

> Researchers at Oregon State University have discovered a group of genes in one species of snail that provide a natural resistance to the flatworm parasite that causes schistosomiasis, and opens the door to possible new drugs or ways to break the transmission cycle of this disease. Release

Suggested Articles

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.